MAPT and tauopathy: Furthermore, our data indicate that tau PET signals in individuals with 4R-tauopathies are driven by dense neuronal and oligodendroglial tau aggregation, whereas faint tau-positive structures of astrocytes and tau fragments are not capable of translating radiotracer binding into in vivo signals.